Sana Biotechnology plans IND filing, targets Phase 1/2 start this year for SC451 type 1 diabetes therapyPUBT·Jul 13 at 07:07 AMSANA+0.30%
Sana Biotechnology (SANA) Is Up 18.1% After Removal From Key Russell Value Indexes - What's ChangedSimplywall·Jul 8 at 02:57 PMSANA+0.30%
Sana Biotechnology to present first-in-human hypoimmune islet transplant data at EASD 2026PUBT·Jul 1 at 08:03 AMSANA+0.30%
Will Removal From Russell Value Benchmarks Change Sana Biotechnology's (SANA) Institutional Investor Narrative?Simplywall·Jul 1 at 03:05 AMSANA+0.30%
Sana Biotechnology, Inc. Stock 12‑Month Price Target Cut to $9.14, Implies 230% UpsideTradingView·Jun 11 at 11:20 PMSANA+0.30%
Did Sana Biotechnology, Inc. Insiders Breach their Fiduciary Duties to Shareholders?PR Newswire·Jun 2 at 05:11 PMSANA+0.30%
Sana Biotechnology Raises $69 Million Through Equity OfferingTip Ranks·May 15 at 03:50 PMSANA+0.30%SBIO-1.49%
Sana Biotechnology (SANA) Receives a Buy from WedbushTip Ranks·May 13 at 09:18 AMSANA+0.30%LABD+1.83%
MileCell Biotechnology Launches New Corporate Website, Appoints Nianwei Lin, PhD, as CEO and Wayne Vaz as CCOMorningStar·May 11 at 09:14 AMSANA+0.30%IBBQ+1.04%
